188 related articles for article (PubMed ID: 34236752)
1. Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients.
Subrahmanian S; Borczuk A; Salvatore S; Fung KM; Merrill JT; Laurence J; Ahamed J
J Thromb Haemost; 2021 Sep; 19(9):2268-2274. PubMed ID: 34236752
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus.
Mackman N; Grover SP; Antoniak S
J Thromb Haemost; 2021 Nov; 19(11):2652-2658. PubMed ID: 34418279
[TBL] [Abstract][Full Text] [Related]
3. Tissue Factor and COVID-19: An Update.
Sachetto ATA; Mackman N
Curr Drug Targets; 2022 Nov; 23(17):1573-1577. PubMed ID: 36165519
[TBL] [Abstract][Full Text] [Related]
4. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
Gando S; Wada T
Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection.
Alba GA; Samokhin AO; Wang RS; Wertheim BM; Haley KJ; Padera RF; Vargas SO; Rosas IO; Hariri LP; Shih A; Thompson BT; Mitchell RN; Maron BA
Pulm Circ; 2022 Apr; 12(2):e12071. PubMed ID: 35599981
[TBL] [Abstract][Full Text] [Related]
6. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.
Puhm F; Allaeys I; Lacasse E; Dubuc I; Galipeau Y; Zaid Y; Khalki L; Belleannée C; Durocher Y; Brisson AR; Wolberg AS; Langlois MA; Flamand L; Boilard E
Blood Adv; 2022 Jun; 6(12):3593-3605. PubMed ID: 35443030
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
10. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.
Whyte CS; Morrow GB; Mitchell JL; Chowdary P; Mutch NJ
J Thromb Haemost; 2020 Jul; 18(7):1548-1555. PubMed ID: 32329246
[TBL] [Abstract][Full Text] [Related]
12. Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi.
Lopuhaä BV; Guzel C; van der Lee A; van den Bosch TPP; van Kemenade FJ; Huisman MV; Kruip MJHA; Luider TM; von der Thüsen JH
Histopathology; 2024 May; 84(6):967-982. PubMed ID: 38253958
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.
Girard TJ; Antunes L; Zhang N; Amrute JM; Subramanian R; Eldem I; Remy KE; Mazer M; Erlich EC; Cruchaga C; Steed AL; Randolph GJ; Di Paola J
J Thromb Haemost; 2023 Mar; 21(3):629-638. PubMed ID: 36696180
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
15. Comparison of In Situ Hybridization, Immunohistochemistry, and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Tissue.
Roden AC; Vrana JA; Koepplin JW; Hudson AE; Norgan AP; Jenkinson G; Yamaoka S; Ebihara H; Monroe R; Szabolcs MJ; Majumdar R; Moyer AM; García JJ; Kipp BR
Arch Pathol Lab Med; 2021 Jul; 145(7):785-796. PubMed ID: 33720333
[TBL] [Abstract][Full Text] [Related]
16. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
[TBL] [Abstract][Full Text] [Related]
17. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.
Schurink B; Roos E; Radonic T; Barbe E; Bouman CSC; de Boer HH; de Bree GJ; Bulle EB; Aronica EM; Florquin S; Fronczek J; Heunks LMA; de Jong MD; Guo L; du Long R; Lutter R; Molenaar PCG; Neefjes-Borst EA; Niessen HWM; van Noesel CJM; Roelofs JJTH; Snijder EJ; Soer EC; Verheij J; Vlaar APJ; Vos W; van der Wel NN; van der Wal AC; van der Valk P; Bugiani M
Lancet Microbe; 2020 Nov; 1(7):e290-e299. PubMed ID: 33015653
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase.
Wang J; Pendurthi UR; Yi G; Rao LVM
Blood; 2021 Jul; 138(4):344-349. PubMed ID: 34075401
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome.
Paul O; Tao JQ; West E; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
Respir Res; 2022 Feb; 23(1):25. PubMed ID: 35144622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
